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Abstract
The repair of dermal tissue is a complex process of interconnected phenom-
ena, where cellular, chemical and mechanical aspects all play a role, both in
an autocrine and in a paracrine fashion. Recent experimental results have
shown that transforming growth factor−β (TGFβ) and tissue mechanics
play roles in regulating cell proliferation, differentiation and the production
of extracellular materials. We have developed a 1D mathematical model that
considers the interaction between the cellular, chemical and mechanical phe-
nomena, allowing the combination of TGFβ and tissue stress to inform the
activation of fibroblasts to myofibroblasts. Additionally, our model incor-
porates the observed feature of residual stress by considering the changing
zero-stress state in the formulation for effective strain. Using this model, we
predict that the continued presence of TGFβ in dermal wounds will produce
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contractures due to the persistence of myofibroblasts; in contrast, early elim-
ination of TGFβ significantly reduces the myofibroblast numbers resulting
in an increase in wound size. Similar results were obtained by varying the
rate at which fibroblasts differentiate to myofibroblasts and by changing the
myofibroblast apoptotic rate. Taken together, the implication is that ele-
vated levels of myofibroblasts is the key factor behind wounds healing with
excessive contraction, suggesting that clinical strategies which aim to reduce
the myofibroblast density may reduce the appearance of contractures.
Keywords: biomechanics, morphoelasticity, zero stress states,
myofibroblasts
1. Introduction
Severance of the dermal layer triggers a repair response that fails to regener-
ate the original architecture of the tissue. Consequently the final outcome,
scar tissue, is both biologically and mechanically inferior to the unwounded
dermis. The overall healing process is complex and can be described in terms
of four overlapping but well-defined stages of wound repair: haemostasis, in-
flammation, proliferation and lastly, remodelling and scar formation (Moulin
et al., 2004; Enoch et al., 2006).
Haemostasis is the initial response to injury, beginning with arresting blood
flow by vasoconstriction. Platelets aggregate at the perforations in the vas-
culature, forming a thrombus. This establishes a fibrin clot in the wound
space that acts as a temporary scaffold over which cells migrate. In addition,
growth factors such as thrombin (Majno and Joris, 2004), platelet-derived
growth factor (PDGF) (Singer and Clark, 1999) and transforming growth
factors β1 and β2 (TGFβ) (Singer and Clark, 1999) are released, attracting
macrophages into the wound space and initiating the inflammatory response.
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Inflammation is triggered irrespective of the presence of infection. Leuko-
cytes such as macrophages, mast cells and neutrophils migrate into the re-
gion, phagocytose damaged tissue and detritus and remove foreign bodies.
These cells release large quantities of growth factors including TGFβ, which
is one of the main regulatory growth factors in dermal repair. TGFβ is
implicated in the stimulation of angiogenesis, the formation of granulation
tissue, the regulation of fibroblast collagen synthesis (Roberts et al., 1992;
Murata et al., 1997; Rhett et al., 2008) and the development of fibropla-
sia; later in the wound healing process it also helps to determine the final
appearance of the scar (Ferguson and O’Kane, 2004). Late in the inflamma-
tory stage TGFβ initiates the recruitment of fibroblasts, the main cell type
in dermal repair, into the lesion. This migration of fibroblasts corresponds
to the beginning of the proliferative phase.
In the proliferative stage, the fibroblasts migrate over the fibrin framework
simultaneously replacing it with a collagen lattice and thereby restoring
the extracellular matrix (ECM) within the wound. Endothelial cells, re-
sponsible for the vascularisation of scar tissue, use the ECM as a scaffold
for the new vessels. Hence, angiogenesis occurs concurrently with prolifer-
ation. Fibroblasts also modulate into their active, contractile phenotype,
the myofibroblast, and together fibroblasts and myofibroblasts effect wound
contraction through physically exerting traction on the collagen fibres and
through remodelling the collagen lattice. Experimental results for rat der-
mal repair have shown that for this contractile phase, the wound size can
be modelled by an exponential decay function (McGrath and Simon, 1983).
Previously, it was known that the activation of fibroblasts to myofibrob-
lasts was TGFβ-dependent (Desmouliere et al., 1993). However, more re-
cent experimental research by Gabbiani (2003), Hinz (2007, 2009, 2010) and
others have shown that mechanical tension is also required to initiate and
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maintain this phenotypic change (Wells and Discher, 2008; Wipff and Hinz,
2009; Eckes et al., 2010). This differentiation is a two-stage process. Firstly,
mechanical tension, the result of the compaction by tractional forces, initi-
ates the activation to proto-myofibroblasts, the precursors to myofibroblasts
(Hinz and Gabbiani, 2003). Proto-myofibroblasts are characterised by ma-
ture focal adhesions and immature actin filaments (Gabbiani, 2003). Further
stimulation by mechanical tension and TGFβ induces the transformation of
proto-myofibroblasts to myofibroblasts. Myofibroblasts are distinguished
from proto-myofibroblasts by the presence of stress fibres in their cytosol in
the form of α-smooth muscle actin (α-SMA) and supermature focal adhe-
sions (Hinz and Gabbiani, 2003). In addition, myofibroblasts are thought
to perform the majority of wound contraction, while fibroblasts primarily
synthesise and remodel the local collagen network.
Once wound closure is complete the scar becomes relatively avascular and
myofibroblasts and leukocytes are no longer present. It is speculated that
myofibroblasts undergo apoptosis (Moulin et al., 2004). Fibroblasts remain,
performing further ECM remodelling that increases the tensile strength of
the scar tissue. The process of scar maturation can last for months or even
years following injury (Majno and Joris, 2004).
It is our purpose to develop a mathematical model that captures the essential
features of the proliferative stage of dermal wound repair and, recognising
the importance of both chemical and mechanical signals within the wound
healing process, we consider a mechanochemical representation.
The majority of mechanochemical models for dermal repair, such as those
of Olsen et al. (1995, 1996, 1997, 1998, 1999), Tracqui et al. (1995), Tran-
qui and Tracqui (2000), Javierre et al. (2009) and Vermolen and Javierre
(2010), are fundamentally based on the seminal work of Tranquillo and
Murray (1992) who considered a linear viscoelastic tissue framework. How-
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ever, this is appropriate only for small deformations and in human dermal
wounds 20-30% of closure is associated with mechanical contraction while
in murine dermal wounds this can be up to 80% (Tranquillo and Murray,
1992; Farahani and Kloth, 2008). Clearly, the deformations that occur in
dermal wound healing are not always small, and so Tranquillo and Murray’s
preliminary mechanical framework is unsuitable. In addition, this model
does not capture the permanent contraction observed experimentally unless
a permanent chemical mediator with a static distribution is invoked.
In the present study, we develop an ordinary differential equation (ODE)
model that incorporates the most important features of wound closure and
that allows for large tissue displacements.
In the next section, we discuss the only other two-compartment morphoelas-
tic model for dermal repair, which was developed by Cook (1995). We then
describe our mathematical representation of dermal wound healing in Sec-
tion 3, and discuss parameter estimation, a crucial aspect of computational
biology. In Section 4, we examine the model predictions and validate the
model against experimental results for wound closure. Finally, in Section 5,
we discuss the implications of our results and describe possible extensions
of the model.
2. The Cook Model
We build upon the work of Cook (1995), who developed an ODE mechanochem-
ical model for dermal repair that accounts for the permanent deformations
and contraction of the tissue during healing. This approach employed the
idea of a zero stress state, which is defined as a state in which each element
of the tissue is unstressed (Goriely and Ben Amar, 2007; Hall, 2009). The
zero stress state is necessarily defined locally, as it may not be possible to
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find a compatible deformation of the entire tissue where every point is simul-
taneously at zero stress. However, it is still possible to develop a consistent
theory with only locally-defined zero stress states by using a multiplicative
decomposition of the deformation gradient. Strain measured relative to the
zero stress state is termed the effective strain, while the classical strain asso-
ciated with being at the local zero stress state is referred to as the residual
strain (Cook, 1995).
Plastic tissue deformation associated with growth and cellular remodelling
leads to changes in the zero stress state. Since the effective strain is measured
relative to the zero stress state, these changes can be incorporated into how
the effective strain develops. We assume the current state is everywhere
a small elastic deformation from the local zero stress state. This enables
us to consider linear elasticity based on the effective strain. In turn, our
formulation for effective strain incorporates many morphological aspects of
tissue repair, such as cellular remodelling of collagen fibres and the growth
of new tissue. Thus, we develop a morphoelastic representation of wound
repair as it can capture both the growth and mechanical considerations
involved in tissue repair.
Cook (1995) uses these ideas to develop a preliminary morphoelastic model
of wound closure. He assumes symmetry about the wound centre at x = 0,
and considers two compartments: one on 0 < x < L, which corresponds
to the wound space and a second on L < x < α, which represents the
undamaged tissue (see Figure 1). In this work, L is the location of the
wound boundary and an increase in L indicates an increase in wound size
(or retraction) while a decrease in L indicates wound contraction. We note
that x = α represents an undisturbed point far from the wound and that
Cook considers a value of α = 1.
This formulation allowed Cook to consider each time-varying species in two
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Figure 1: Wound compartment diagram.
forms: one inside the wound and another outside. Cook thus simplified
his full model to one that contained only time derivatives. Since the full
model included advection, this ODE approach required a representation of
the spatial derivative of the velocity; Cook used the approximation
∂v
∂x
=

1
L
dL
dt 0 < x < L,
−1
L−α
dL
dt L < x < α.
Combining these ideas, Cook developed the following 1D non-dimensional
model of wound closure:
dn
dt
= n(1− n)− n
L
dL
dt
,
dz
dt
=
κq(s)n
s
,
ds
dt
= κn(1− s)− s
L
dL
dt
,
dS
dt
=
S
1− L
dL
dt
,
SE = s+ τ(n), τ(n) = τ0n(1− n)θ,
 =
L− L0
L
− z, E = L− L0
L− 1 ,
q(s) =

1− sβ if s < β,
0 if s > β.
Here n is the fibroblast density, s and S are the collagen densities inside
and outside the wound respectively,  and E are the effective strains inside
and outside the lesion, z is the residual strain, τ is the cell traction, κ is the
production rate of collagen, 2L0 is the initial wound size, τ0 is a parameter
characterising the cell traction, θ is a parameter that modifies the logistic
form adopted for the cell traction dependence on fibroblast density, q(s)
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represents the proportion of fibres laid down in a relaxed state and β is the
threshold value of the residual strain above which alterations to the residual
strain are negligible.
While Cook (1995) was able to describe permanent wound contraction with
his model, a feature not observed in any of the previous models, there are
several shortcomings, which we now describe.
Despite previous research by Tranquillo and Murray (1992) concluding that
an inflammatory mediator is essential in wound repair, Cook (1995) neglects
all chemical effects. In order to effect wound contraction, Cook instead as-
sumes that the cell traction stress is biphasic. In contrast, Tamariz and
Grinnell’s (2002) experiments suggest that tractional stress is a monoton-
ically increasing function of cell density, consistent with previous models
of dermal repair such as those of Tranquillo and Murray (1992) and Olsen
et al. (1995). A further problem with Cook’s formulation is that it leads
to a situation where there is no tension in the healthy skin or the healed
wound; this is unrealistic (Reihsner et al., 1995).
Cook also models the effective strain explicitly. He assumes that it is gov-
erned by the movement of the wound boundary and, inside the wound, the
residual strain. While Cook allows the residual strain to evolve by incor-
porating the effect of cells laying down new fibres, he ignores the action of
cells actively remodelling the collagen matrix. However, in fibroblast pop-
ulated collagen lattice experiments by Grinnell et al. (2003), it was found
that significant permanent contraction occurs as a result of fibroblasts phys-
ically remodelling the lattice. We incorporate a new representation of the
evolution of effective strain that includes these effects.
Finally, Cook neglects the synthesis of collagen in the unwounded region.
Consequently, the steady state value of the collagen density outside the
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wound is history-dependent. Hence, the collagen density inside the wound
tends to healed levels but the collagen density outside the wound may not.
In the proposed mechanochemical wound repair model, we have addressed
these issues and also extended Cook’s model to include the presence of my-
ofibroblasts and the effects of TGFβ.
3. Proposed Mathematical Model
3.1. Two-Compartment Model of Wound Repair
Following Cook (1995), we consider a two-compartment model for wound
repair. We assume symmetry about the wound centre at x = 0 and take
x = L(t) to represent the time-dependent wound boundary, with 0 < x < L
corresponding to one half of the wound space. We also assume that there is
a fixed point, x = α, that is sufficiently far from the wound space that the
tissue is undisturbed there. In our model, L < x < α therefore corresponds
to the unwounded dermis. We also note that the proliferative stage occurs
over approximately a one month period (Enoch and Leaper, 2007) and so
we measure time, t, in days.
Our model examines the interactions between cells, TGFβ, ECM and wound
mechanics. We consider eight dependent variables: the fibroblast density
inside and outside the wound (n and N respectively), the myofibroblast
density in the wound (m), the TGFβ concentration within the wound (β),
the ECM density within and without the wound (s and S, respectively), the
effective strain within and without the wound (e and E, respectively), and
the location of the wound boundary (L).
Fibroblasts are assumed to undergo logistic growth, to transform into myofi-
broblasts in response to mechanical stimuli and to advect with the moving
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ECM. It is known that fibroblasts migrate into the wound space from the
surrounding dermis and we model this with a simple form: the recruitment
of fibroblasts to the wound is taken to be proportional to the difference be-
tween the fibroblast density in the undamaged tissue and the density in the
wound. Hence, the fibroblast equation takes the form
dn
dt
= gn
(
1− n
Nˆ
)
+
R(N − n)
L
− rKβen− n
L
dL
dt
, (1)
N(t) = Nˆ , (2)
where g is the intrinsic growth rate of fibroblasts, Nˆ represents the un-
wounded density of fibroblasts, R represents the rate at which cells migrate
into the wound from the unwounded dermis, r characterises the activation
rate of fibroblasts to myofibroblasts, and K is the elastic modulus of the
dermis. Assuming tissue stiffness to be proportional to collagen density, we
find that K = Y s, where Y is a constant of proportionality.
The activation term, rKβen, has been chosen since fibroblasts are activated
to myofibroblasts by the presence of TGFβ (β) and tensile stress. It should
be noted that elastic stress (Ke) is used, rather than traction stress or total
stress. This can be justified by noting that the traction stress is in fact a
body force due to the action of cells. Moreover, a simple comparison of the
elastic stress and traction stress profiles in the Tranquillo and Murray (1992)
model makes it clear that elastic stress is the most appropriate for govern-
ing the activation of fibroblasts. The elastic stress monotonically decreases
with distance away from the wound centre while traction monotonically
increases. If the modulation of fibroblasts to myofibroblasts were depen-
dent on cell traction, the monotone increase in stress would mean that the
highest rate of differentiation of fibroblasts to myofibroblasts would happen
outside the wound. However, using the elastic stress leads to the sensible
result where activation is highest in the wound. This behaviour is consistent
with the observation by Hinz et al. (2001) that myofibroblast differentiation
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slows, or is even arrested, upon release of tension from splinted wounds. As
the wound contracts, the elastic stress decreases and the rate of the myofi-
broblast differentiation also slows. This phenomenon is observed regardless
of the magnitude of the initial cell traction outside the wound space.
As mentioned above, myofibroblasts are assumed to be present only within
the wound space and the only source of myofibroblasts is taken to be the
activation of fibroblasts. Myofibroblasts are assumed not to transform back
to fibroblasts, instead undergoing natural cell death (apoptosis) (Moulin
et al., 2004). In addition, these cells are advected as the ECM moves.
Hence, the governing equation for the myofibroblast density is
dm
dt
= rKβen− am− m
L
dL
dt
, (3)
where a characterises the rate of myofibroblast apoptosis.
Fibroblasts migrate into the wound space 2-4 days post-wounding (Enoch
and Leaper, 2007) and experimental results by Yang et al. (1999) show that
there is a large concentration of TGFβ in the wound space at around this
time, which then decays approximately exponentially. In our model, where
t = 0 represents day 2 post-wounding, we therefore assume that TGFβ can
be modelled by an exponential decay function of the form
β(t) = β0exp (−bt) , (4)
where β0 is the initial concentration of TGFβ and b is the natural decay
rate.
The ECM is synthesized by both the fibroblasts and myofibroblasts, with
production ceasing once unwounded levels are obtained. Both the ECM
inside the wound and the ECM outside the lesion undergo advection as the
wound retracts and contracts. Based on these assumptions, the governing
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equations for ECM density are
ds
dt
= k1(n+ ηm)− k2(n+ δm)s− s
L
dL
dt
, (5)
dS
dt
= k1N − k2NS + S
α− L
dL
dt
, (6)
where k1 and k2 are the synthesis and degradation rates of ECM by fibrob-
lasts respectively, and η and δ are the synthesis and degradation rates of
ECM by myofibroblasts relative to fibroblasts.
Strain in the ECM develops as cells rearrange the matrix, generating tension
in the fibres, and is reduced when new fibres are laid down in a relaxed state.
Advection also affects the local strain, with the effect of tissue elasticity
represented in the (1/L)dL/dt term. We consider a form of the effective
strain based upon Hall’s (2009) repair description, obtaining the following
governing equations for strain inside and outside the wound:
de
dt
= kζs(n+ piζm)− kρ(n+ piρm)e
s
+
(1− e)
L
dL
dt
, (7)
dE
dt
= kζNS − kρNE
S
− (1− E)
α− L
dL
dt
, (8)
where kζ is the rate at which fibroblasts cause permanent contraction of the
ECM, piζ represents the rate of permanent contraction due to myofibroblasts
relative to fibroblasts, kρ is the rate of matrix turnover as a result of replac-
ing stressed fibres with unstressed fibres and piρ represents the remodelling
achieved by myofibroblasts relative to that of fibroblasts. Here kζ , kρ, piζ ,
piρ are all constants.
It is assumed that there are no body forces apart from those due to cell
traction. Consequently, the tissue forces (due to elastic and cell traction
stress) inside and outside the wound must balance, leading to
Y se+ τ(n+ ζm)s = Y SE + τNS, (9)
where τ is a constant measuring the fibroblast traction and ζ represents
the strength of myofibroblasts relative to fibroblasts. This formulation also
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assumes an abrupt interface between the wound and unwounded dermis. In
an acute wound this interface is gradual. However, since the width of this
interface is typically much smaller than the wound width, this represents a
reasonable assumption. We note that in Cook’s model the cell traction term
is independent of collagen density; here, we take it to be directly proportional
to s, in line with Tranquillo and Murray (1992). From (9), the governing
equation for the wound boundary
dL
dt
=
Y
{
κ [E(1− S)− (n+ ηm)(1− s)e] + kζ
[
S2 − (n+ pim) s2]}
s
L {Y (1− 2e)− 2τ(n+ ζm)}+ Sα−L {Y (1− 2E)− τ}
−Y kρ [E − (n+ ηm) e] + τκ [(1− S)− (n+ ηm)(1− s)(n+ ζm)]
s
L {Y (1− 2e)− 2τ(n+ ζm)}+ Sα−L {Y (1− 2E)− τ}
+τ
{
rY s2enβ(1− ζ) + ζasm− s(1− n) (n+R/L)}
s
L {Y (1− 2e)− 2τ(n+ ζm)}+ Sα−L {Y (1− 2E)− τ}
is obtained by differentiating (9) with respect to time, substituting in equa-
tions (1)-(8), and rearranging for dL/dt.
The system is non-dimensionalised (see Appendix B), and from this point
on we consider the following non-dimensional equations, dropping bars for
convenience:
dn
dt
= n (1− n) + R(1− n)
L
− rY βsen− n
L
dL
dt
, (10)
dm
dt
= rY βsen− am− m
L
dL
dt
, (11)
β(t) = exp (−bt) , (12)
ds
dt
= κ(n+ ηm)(1− s)− s
L
dL
dt
, (13)
dS
dt
= κ(1− S) + S
1− L
dL
dt
, (14)
de
dt
= kζs(n+ pim)− kρ(n+ ηm)e
s
+
(1− e)
L
dL
dt
, (15)
dE
dt
= kζS − kρE
S
− (1− E)
1− L
dL
dt
, (16)
Y SE + τS = Y se+ τ(n+ ζm)s. (17)
Since N(t) ≡ 1, we no longer consider the fibroblast density outside the
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wound space. Note, the problem is scaled so that one unit of time represents
approximately one day.
Recall that we are modelling the second stage of wound healing, the prolif-
erative phase. We assume that, initially, the scaled ECM density and the
effective strain outside the wound space are given by
S(0) = 1 and E(0) =
kζ
kρ
,
their unwounded values. It is assumed that the wound is small and hence
there is a very small population of fibroblasts in the wound initially. Addi-
tionally, we assume that there is a small amount of collagen already within
the wound space. Based on these assumptions we use the initial conditions
L(0) = 0.1, n(0) = 0.001 and s(0) = 0.25.
The strain inside the wound, e, must satisfy the force balance equation, (17),
thus
e(0) =
kζ
kρs(0)
+
τ
Y s(0)
− τn(0)
Y
.
With these initial conditions, the full dimensionless system of (10)-(17) can
be solved using MATLAB’s inbuilt ordinary differential equation routine,
ode45.
3.2. Parameter Estimation
One complication common to almost all mathematical representations of
biological systems is that it is usually impossible to determine the values
of all the parameters directly from experimental evidence. In some cases,
an appropriate value can be estimated based on experimental results or
a plausible range can be determined; nonetheless, some parameters may
need to be estimated from numerical simulations so that the predictions
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are physically realistic. Clearly, assigning parameters values is a nontrivial
process.
In Table 1 we present the parameters we used in our model; this table also
includes a description of whether the value was known, calculated or esti-
mated and, where appropriate, references are provided. Fortuitously, the
sensitivity analysis in Section 4 shows our model to be quite robust to sig-
nificant variations in a number of parameter values. This means that we
can have some confidence that the solutions obtained with these parame-
ter values is indicative of the solution trajectory for physiologically correct
parameter values.
In the morphoelastic representation of tissue dynamics that we use, we as-
sume that the zero stress state is close to the current state. This implies
that the effective strain is small (i.e. e 1) and enables us to assume linear
elasticity. Given that the steady state of the effective strain in healthy skin
is kζ/kρ, this indicates that kζ  kρ. With this in mind, we choose kρ and
kζ such that kζ/kρ is O(10
−2).
A wide range of values are reported in the present literature for the mag-
nitude of traction forces exhibited by human dermal fibroblasts; estimates
range from 0.1nN/cell (Eastwood et al., 1994, 1996, 1998; Campbell, 2002;
Wrobel et al., 2002; Shreiber et al., 2003) to 2.65µN/cell (Delvoye et al.,
1991; Fray et al., 1998). There is a number of possible reasons for this
apparent discrepancy. Firstly, there is a lot of variation in the matrix ma-
terial upon which the cells are seeded. While fibroblast populated collagen
gels appear to be the most widely used, 3-D bio-artificial hydrogels (Zaha-
lak et al., 2000), GAG-collagen scaffolds (Freyman et al., 2001), elastomers
(Wrobel et al., 2002) and other 3-D constructs (Harley et al., 2007) have also
been employed. Additionally, different experiments involve matrices of dif-
ferent stiffnesses with elastic moduli ranging from 40Pa to 70GPa (Freyman
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Non-Dimensional Parameter Range Reference
R, Ingress of fibroblasts R ≈ 0.04 Sillman et al. (2003)
r, Fibroblast activation r ≈ 0.22 Desmouliere et al. (1993)
to myofibroblasts
a, Myofibroblast apoptosis 0.096 < a < 0.24 Moulin et al. (2004)
b, TGFβ decay b ≈ 0.426 Est. from Yang et al. (1999)
κ, Collagen production 0.1− 1 TW
η, Relative collagen production 2 Moulin et al. (1998),
by myofibroblasts Olsen et al. (1995)
kζ , Contractile strain produced 0.002 < kζ < 0.02 TW
by fibroblasts
kρ, Matrix turnover by fibroblasts 0.2 < kρ < 2 TW
pi, Myofibroblast to fibroblast 15 TW
contractile strain generation
Y , Elastic modulus 10 < Y < 300 Silver et al. (2001),
Genzer and Groenewold (2006)
τ , Fibroblast cell traction 1 < τ < 3 Fray et al. (1998),
Wrobel et al. (2002)
ζ, Myofibroblast to fibroblast ζ ≈ 5 Olsen et al. (1995)
cell traction
n0, Initial fibroblast density 0.001 Cook (1995)
s0, Initial collagen density 0.25 TW
L0, Initial wound boundary 0.1 Cook (1995)
Table 1: Table of parameters. Unless otherwise specified, these parameters
are used for all simulations. TW refers to estimations made during this
work. For determination of the dimensional parameter values see Appendix
Appendix B.
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et al., 2001, 2002; Campbell, 2002). None of these experiments considered a
modulus between 0.1− 0.7MPa, the approximate stiffness of human dermal
tissue (Diridollou et al., 2000; Silver et al., 2001; Khatyr et al., 2004; Genzer
and Groenewold, 2006; Ahlfors and Billiar, 2007; Kucharova et al., 2007),
although it is possible to manufacture collagen gels that possess an elastic
modulus in the appropriate range (Chapuis and Agache, 1992; Ahlfors and
Billiar, 2007). As cell traction strength is thought to vary significantly with
tissue stiffness, the failure of experimental research to adequately control for
tissue stiffness might account for the large variation in measured tissue stiff-
nesses. Moreover, the failure to use lattices of stiffness similar to that of the
skin means that what results have been obtained may not be physiologically
relevant.
Moreover, there is no consistency in the method used to determine the cell
traction force. Current methods include studies of free-floating fibroblast-
populated collagen lattices (Li and Wang, 2009), the use of cellular force
monitors (Freyman et al., 2002), micropost force sensor arrays (Li and Wang,
2009), and cell traction force microscopy (Fray et al., 1998; Li and Wang,
2009). These different techniques seem to yield inconsistent measurements
of the cell traction force and there is a need for further work to harmonise
the various experimental approaches.
Also, it is possible that the variation in cell traction estimates is associated
with mixed populations of fibroblasts and myofibroblasts and with the effects
of fibroblasts differentiating into myofibroblasts. Myofibroblasts are known
to function in a manner similar to smooth muscle cells, and cell traction
values of 1µN/cell are close to those of smooth muscle cells at 1.5µN/cell
(Wakatsuki et al., 2000). Hence, cell traction values around 1nN/cell may
correspond to the force generated by fibroblasts, while values near 1µN/cell
may be associated with myofibroblasts.
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We have also reviewed the non-dimensional values of the traction force used
by previous biomathematicians who have modelled dermal repair. Even
amongst these papers there are discrepancies. There are two clusters of val-
ues used by researchers; some authors used cell traction parameters in the
range 0.02−0.05 (Olsen et al., 1995; Ferrenq et al., 1997; Tranqui and Trac-
qui, 2000) while others took traction to be in the range 0.5− 2 (Tranquillo
and Murray, 1992; Cook, 1995; Tracqui et al., 1995; Tranqui and Tracqui,
2000; Ramtani et al., 2002; Ramtani, 2004). It is possible that this dis-
crepancy is partly due to the different non-dimensionalisations used by the
authors. The cell traction parameter depends on the scaling of cell den-
sity, which varies significantly in different papers from O(103) to O(106)
(Olsen et al., 1996; Ferrenq et al., 1997). This may account for the order of
magnitude variation in the non-dimensionalised cell traction parameter.
The previous model by Cook (1995) (on which this work is based) used
a non-dimensional cell traction value of 2. Therefore, it is reasonable to
assume that the non-dimensional value of cell traction in this work should
be of O(1). Consideration of the scaling then implies that the cell traction
force is approximately 2µN/cell, consistent with Kolodney and Wysolmerski
(1992), Fray et al. (1998), Wakatsuki et al. (2000), Wrobel et al. (2002) and
Wagenseil and Okamoto (2007).
4. Results
Following Cook (1995), we consider the effect of varying particular param-
eter values on the system. The significant results are summarised in Table
2.
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4.1. Base Results
In the base system (illustrated in Figure 2) we see that the fibroblast density,
n, increases rapidly over the first week of wound repair, essentially reaching
near-healed densities around day 5. Myofibroblasts undergo the greatest
activation early on, achieving a maximum density on day 3, after which the
myofibroblast density, m, decreases due to a reduction in the number of
fibroblasts activated to become myofibroblasts. This decrease is primarily
associated with the decay of TGFβ; as β decreases, there is a corresponding
reduction in the activation of fibroblasts to myofibroblasts.
The collagen density inside the wound, s, follows the fibroblast profile with
a lag, attaining close to a healed density by day 12. Changes in the collagen
density outside the wound, S, are entirely mediated by the advection of the
wound boundary. Thus, S increases during the retraction phase, decreases
while the wound contracts and finally tends towards healed levels as the
damaged dermis is repaired.
Initially, the wound boundary, L, retracts. This expansion in wound size is
due to the unbalanced stressed acting on the wound boundary. As Watts
(1960) comments, “contraction is essentially a cellular process affecting the
edge of the wound.” Early in the healing process, there is greater cell traction
stress outside the wound than within it. As such, the wound boundary is
pulled open. Typically, retraction occurs over the first 2 days of wound repair
(Billingham and Medawar, 1955; McGrath and Emery, 1985), and we predict
maximum retraction to occur just following two days of repair. As the wound
space is repopulated with fibroblasts and as fibroblasts are transformed into
myofibroblasts, cell traction stress within the wound increases beyond that
of the surrounding tissue, and wound contraction results.
This ensuing contractile phase is approximately exponential in nature. The
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Figure 2: Dermal repair profiles predicted by the model. Parameter values were
κ = 0.27, τ = 2, kζ = 0.0054, kρ = 0.54, Y = 71.3, R = 0.04, r = 0.22, a = 0.2,
ζ = 5, pi = 15, η = 2 and b = 0.426.
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contractile phase is highly dependent on the presence of myofibroblasts.
However, fibroblast activation decreases as the wound heals; fewer myofi-
broblasts are generated and apoptosis dominates, reducing the density of
myofibroblasts. This causes contraction of the wound to decrease also, reach-
ing a plateau stage where further contraction is negligible. By this stage, it
is observed that approximately 10% of wound closure has been effected by
wound contraction, which is consistent with previous predictions of human
dermal wound repair (Murray, 2003).
4.2. Varying the activation rate of fibroblasts, r
As expected, increasing (decreasing) the activation rate of fibroblasts to
myofibroblasts significantly increases (decreases) the myofibroblast density
(see Figure 3), while having only a limited effect on fibroblast density. If the
activation rate is very small, there are few myofibroblasts. As a result, the
total traction stress associated with the cells is significantly weaker and the
wound boundary may retract and stay retracted (instead of contracting). In
contrast, if the activation rate is quite high, there may be no initial retrac-
tion. Thus, the system exhibits contraction only and, due to the increased
myofibroblast density, the contraction of the wound boundary is significantly
increased. Variations in the remainder of the system are essentially due to
advection.
4.3. Varying the rate of myofibroblast apoptosis, a
When the apoptotic rate of myofibroblasts is increased so that myofibrob-
lasts die out rapidly, there is only a marginal difference in the fibroblast
profile (see Figure 4).
In the case where myofibroblast apoptosis is small, the effective strain in-
side the wound is reduced, decreasing the activation rate and causing the
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Figure 3: The fibroblast activation rate was varied by multiplying or dividing the
base activation rate of 0.22 by 10, so that the activation rates considered were
r = 2.2 (- -), r = 0.22 (-) and r = 0.022 (..). The other parameter values were
κ = 0.27, τ = 2, kζ = 0.0054, kρ = 0.54, Y = 71.3, R = 0.04, a = 0.2, ζ = 5,
pi = 15, η = 2 and b = 0.426.
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Figure 4: The rate of myofibroblast apoptosis was varied by roughly one order of
magnitude from the base rate of 0.2, so that the death rates considered were a = 2
(- -), a = 0.2 (-) and a = 0.03 (..). The other parameter values were κ = 0.27,
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and b = 0.426.
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fibroblast density to achieve unwounded levels more quickly. While the
activation rate is small in this case, the maximum myofibroblast density
significantly increases with decreasing apoptotic rate since myofibroblasts
persist for longer. Indeed, for sufficiently small apoptosis the myofibroblasts
increase collagen density within the wound space and cause excessive wound
contraction, both of which persist for some time following wound closure.
In summary, increasing (decreasing) the rate at which myofibroblasts un-
dergo apoptosis causes the system to behave in a manner similar to when
the fibroblast differentiation rate is decreased (increased). For instance, in-
creasing the activation rate resulted in excess collagen, while decreasing the
myofibroblast apoptotic rate predicted the same outcome.
4.4. Varying the decay rate of TGFβ, b
Decreasing the decay rate of TGFβ achieves a similar effect to reducing my-
ofibroblast apoptosis (see Figure 5). When TGFβ persists, the activation
of fibroblasts to myofibroblasts is prolonged. Consequently, myofibroblasts
remain following wound closure, causing a mild increase in collagen produc-
tion within the wound space as well as continued severe wound contraction.
If, on the other hand, the decay rate is increased, fibroblast differentiation
ceases quickly and few myofibroblasts are produced. This causes the wound
boundary to retract permanently and in this case, the wound expands to
cover an area approximately 120% that of the original.
4.5. Comparison with Experimental Data
Currently, there is no experimental data for human full thickness wounds
showing the three phases of wound boundary movement (retraction, expo-
nential contraction and permanent contraction). Multiple studies measuring
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Figure 5: The decay rate of TGFβ was varied by multiplying or dividing the base
decay rate of 0.1 by 10, so that the decay rates considered were b = 4.26 (- -),
b = 0.426 (-) and b = 0.0426 (..). The other parameter values were κ = 0.27, τ = 2,
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wound contraction have been conducted (Billingham and Medawar, 1955;
Billingham and Russell, 1956; Grillo et al., 1958; Watts, 1960; Luccioli et al.,
1964; Kennedy and Cliff, 1979; Doillon et al., 1987). However, the results
that most ably illustrate the three stages of wound movement are those ob-
tained by McGrath and Simon (1983). Therefore, the model was tested by
comparing our predictions with McGrath and Simon’s (1983) experimental
results of rat wound contraction. Figure 6 shows their experimental results
plotted against our simulation curve.
The only alteration made to the parameter values was to the values of
kρ, which reflects the proportion of collagen fibres that are laid down pre-
stressed, and kζ , the rate at which fibroblasts cause permanent strain in
the lattice. In the early figures, we have used kζ = 0.0054 and kρ = 0.54,
but the McGrath-Simon data can be fitted well with the values kζ = 0.0235
and kρ = 0.81. Hence, it appears that, in comparison with human wound
healing, rat dermal repair involves greater contraction of collagen fibres rela-
tive to collagen production. This is consistent with the observation that rat
wounds heal primarily by contraction while human injuries heal primarily by
migration and proliferation. Indeed, rat skin contains an additional organ,
the panniculus carnosus, which changes the elasticity of the skin and acts to
pull the wound closed mechanically. This affects the mechanical behaviour
of the skin and would need to be reflected within our model. Since the pan-
niculus carnosus moves the substratum of the skin and effectively holds the
wound closed while it heals, we expect that the presence of the panniculus
carnosus should principally affect the morphoelastic properties of the skin.
This is consistent with the fact that we obtain a good fit between our model
and the McGrath-Simon data by modifying the parameters kρ and kζ , which
both appear in the strain evolution equation.
From Figure 6, it appears that the time scale of retraction is different as
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Figure 6: Comparison of our predicted curves with McGrath and Simon’s (1983)
experimental results for rat dermal repair. All black curves correspond to our simu-
lated results, the red points on the wound boundary figure correspond to McGrath
and Simon’s experimental results, and the blue curve has been fitted to the contrac-
tile phase of our simulation to illustrate that exponential contraction is observed,
with its equation given by A(t) = 0.28 + 1.49exp(−0.141t). Clearly we see that
there is a large initial retraction followed by a slow permanent contraction. The
fibroblasts and collagen increase to unwounded values and the TGFβ concentration
tends to zero. Myofibroblasts increase while the TGFβ concentration is high, until
apoptosis dominates and the myofibroblast density tends to zero. The parameter
values were κ = 0.27, τ = 2, kζ = 0.0235, kρ = 0.81, Y = 71.3, R = 0.04, r = 0.22,
a = 0.2, ζ = 5, pi = 15, η = 2 and b = 0.426. In order to compare dimensional
and non-dimensional results we scaled time in McGrath and Simon’s data by the
same factor that time was non-dimensionalised by for our model; the fibroblast
proliferation rate, g, where g = 0.832/day.
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predicted by the model and observed in McGrath and Simon’s (1983) ex-
perimental data. Rat dermal tissue is highly elastic and typically retracts
fully over the first day of repair. However, wound geometry may affect the
time at which maximum retraction is observed. McGrath and Simon (1983)
observed small square wounds to require approximately one and a half days
to retract, while circular wounds (as seen in Figure 6) retract over the first
day of repair. The model predicts wound retraction to terminate on day 3.
The difference is likely due to the inability to approximate values for the
strain parameters kρ and kζ and that in lieu of a measure for the elasticity
of rat tissue, the Young’s modulus for human dermis has been used.
To verify that the model predicted exponential contraction of the wound,
the following exponential decay function was fitted to the contractile stage
of the simulation curve,
A(t) = Af + (A0 −Af )exp(−kt),
where A0 is the wound size when contraction begins and Af is the final area
once contraction is completed. The constants A0 and Af are both scaled
with respect to L0 and k is the contraction rate constant. It was found
that values of A0 = 2.05, Af = 0.279 and k = 0.141 generated the best
approximation to the simulation curve and the approximation is shown as
the dashed curve in Figure 6. This exponential function closely modelled the
contractile phase of wound repair; as such we are satisified that the model
predicts an exponential rate of wound contraction.
From Figure 6, we see that the model simulation appears to make a good
approximation to the contraction data from McGrath and Simon (1983).
To verify this, we quantitatively compare the experimental wound boundary
data from McGrath and Simon (1983) with our model predictions and the
exponential curve fitted to our simulation. Table 3 gives the scaled values
for initial wound size, maximum retraction, one month following wounding,
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and after 71 days observed by McGrath and our simulation curves. The
final measurement is given at 71 days post wounding as this represents the
time at which McGrath and Simon ceased recording data for rat wound
contraction.
Series Initial Maximum One Month Final
Retraction (71 Days)
McGrath 1.000 1.284 0.2914 0.3048
Model 1.000 1.286 0.2973 0.2817
Exponential - 1.439 0.3041 0.2787
Table 3: Data from McGrath and Simon (1983) together with the corre-
sponding predictions from our model. Wound measurements are typically
carried out to one month, as such we include these measurements together
with the initial wound area, maximum wound area following retraction and
final wound area at 71 days.
From Table 3, we can see that our model predictions are very similar to
the experimental data obtained by McGrath and Simon (1983). This con-
firms that good agreement is seen between the model predictions and the
experimental data. The only noticable difference occurs when comparing
the one month and final measurements. The wounds observed by McGrath
and Simon were observed to experience late retraction. Our model how-
ever predicted a mild further contraction to occur over the same period of
time. Nonetheless, the difference between this measurements is so small as
to be considered negligible. Regardless, the model compares well with the
experimental data. When comparing the model predictions and exponential
curve, good agreement is also seen, apart from the maximum contraction.
However, both from Table 3 and Figure 6 it can be seen that the exponential
curve ably approximates the simulation curve.
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Finally, good agreement is observed between the experimental and simulated
results and so we are satisfied that the model is producing realistic results.
5. Discussion
We have developed a mechanochemical model of wound repair that combines
a realistic representation of tissue mechanics with known cell and chemical
indicatory dynamics. In particular, we consider a morphoelastic description
of tissue mechanics. This gives an improved representation of strain within
the system by incorporating remodelling and growth of the tissue. In addi-
tion, the activation of fibroblasts to myofibroblasts is taken to be dependent
on both TGFβ and mechanical strain, consistent with recent experiments
(Hinz, 2007; Wells and Discher, 2008). Finally, we incorporated deposition
and degradation of collagen into our model and developed a force balance
equation to include the contribution of myofibroblasts to cell traction.
This representation of dermal repair is capable of reproducing the contractile
behaviour of acute wounds, simulating the two transient aspects of wound
closure (retraction and exponential contraction) as well as the permanent re-
duction in wound area observed experimentally (McGrath and Simon, 1983;
McGrath and Emery, 1985). This repair description is an advance on previ-
ous models of wound repair since it does not require an artificial mechanism
to induce permanent wound contraction. In addition, the model has been
shown to reproduce McGrath and Simon’s (1983) experimental data for rat
dermal repair and, using realistic parameter values, it accurately models the
course of adult human dermal repair.
A parameter investigation was carried out to determine the influence of
TGFβ concentration and myofibroblast density on the wound healing pro-
cess. Variation of the decay rate of TGFβ was used as an indicator of the
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length of the inflammatory response, with small decay rates indicating a long
inflammatory response. In the case of “inflamed” wounds, a myofibroblast
population is maintained after wound closure, ultimately resulting in excess
contraction. For a short inflammatory response, the myofibroblast density
decreases rapidly and there is in an increase in wound size.
These results suggest that TGFβ is required for wound contraction; a de-
ficiency in TGFβ results in very few myofibroblasts and this leads to an
increase in wound area. However, an excessive inflammatory response re-
sults in a heightened myofibroblast density and the possible developement
of contractures.
In further simulations it was found that certain other parameter changes
could lead to similar results. Indeed, the effect of a long inflammatory
response could be replicated by either increasing the fibroblast activation
rate or by decreasing myofibroblast apoptosis. Hence, there are different
mechanisms that can initiate pathological scarring. Indeed, work by Aarabi
et al. (2007) found that application of mechanical loading of murine wounds
during the early proliferative stage resulted in the formation of hypertrophic
scars due to down-regulated myofibroblast apoptosis. Likewise, our results
suggest that an elevated myofibroblast density is key to invoking excessive
contraction of wounds. Indeed, to verify this idea the system was extended to
include stress dependence for myofibroblast apoptosis. The results, which for
brevity are not included here, found that significantly more myofibroblasts
were required to undergo apoptosis then when myofibroblast apoptosis is not
stress dependent in order to obtain normal repair. Therefore, if a wound
appears to be exhibiting severe contraction, it may be beneficial to reduce
the myofibroblast density within the wound to prevent the development of
a problematic contracture.
A reasonable fit to McGrath and Simon (1983)’s experimental data was
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obtained by adjusting just two parameters: kρ, the proportion of fibres laid
down that are prestressed, and kζ , the rate of morphoelastic remodelling
of the collagen network by cells acting on collagen fibres. The parameter
kρ was increased from 0.54 to 0.81, representing an increased percentage of
prestressed fibres in the healing wound. The parameter kζ was also increased
from 0.0054 to 0.0235, representing a four-fold increase in the contractile
strain produced by cells. This indicates a difference between the repair
responses of human and murine wounds. The significant increase in the value
of kζ from human to murine repair indicates that murine wounds achieve
closure with significantly more contraction that human dermal wounds (a
fact supported by experimental evidence). Furthermore, the high kρ value
compared with the kζ value in human repair indicates that repair is primarily
attributable to synthesis of collagen and cellular proliferation. Thus, our
model suggests human wounds heal mainly by infilling, which is consistent
with experimental observations.
Significant difficulties were encountered when obtaining reliable experimen-
tal estimates of some parameter values, especially parameters pertaining to
mechanics. As noted above, the variability in experimental values for fibrob-
last traction reflects the wide range of matrix polymers, matrix elasticities
and measurement techniques used in the experiments. We estimated pa-
rameter values by fitting to the qualitative details of human wound healing.
However, the fact that it is possible to synthesise collagen lattices with sim-
ilar mechanical properties to the skin suggests that it may be possible to
develop better estimates based on experiments.
The model could be extended in various ways. For example, the represen-
tation of the matrix present in the wound before the healing process begins
could be improved. It is known that a provisional matrix composed largely
of fibrin is present in the wound at the beginning of the proliferative phase.
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Fibroblasts degrade this fibrin network, replacing it with collagen (Shultz
et al., 2005; Enoch and Leaper, 2007). Although the current initial condition
of s(0) = 0.25 could be thought of as representing the fibrin, we would like
to model the fibrin and collagen separately, with the fibroblasts degrading
the local fibrin matrix and replacing it with collagen. The contribution of
the fibrin lattice towards tissue stiffness and cell traction would be included.
Taken together, this would enable a smaller initial collagen concentration
to be considered, which would more realistically describe the early stages of
wound healing.
Another aspect of the system that could be revised is the representation
of the inflammatory response and its impact on the proliferative phase of
wound repair. There are a number of key chemokines released during the
inflammatory response and these chemokines affect the progress of prolifera-
tion. Indeed, defective inflammation is implicated in poor healing responses
such as chronic wounds and pathological scarring. Additionally, greater in-
teraction between the cellular and chemical components would be a useful
way of extending the model. For example, TGFβ is known to upregulate fi-
broblast proliferation and act as a chemoattractor for these cells. However,
the inflammatory response itself is very complicated, with macrophages,
mast cells, neutrophils and platelets all playing significant roles. Each of
these cells are also primary sources of inflammatory mediators in wound re-
pair, such as TGFβ, PDGF, basic fibroblast growth factor (bFGF), platelet
activating factor (PAF) and many more (Majno and Joris, 2004). A simple
extension of the model would be to include an equation for a generic in-
flammatory cell, perhaps a leukocyte, where its behaviour is representative
of the net inflammatory response of these cells. In so doing, we would also
be modelling one of the primary sources of TGFβ, and so the behaviour of
TGFβ within the system would also be more realistic.
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One inflammatory cell that is known to be directly linked to the fibrotic re-
sponse is the mast cell (Majno and Joris, 2004). Mast cells are recruited early
in the inflammatory process and release vast quantities of growth factors via
degranulation. Amongst these is PAF, which aids the platelet cascade and
the subsequent release of inflammatory mediators, and bFGF, which stim-
ulates fibroblast proliferation and recruitement to the wound site. Hence,
instead of modelling a generic inflammatory cell, a possible extension would
be to explore a single aspect of inflammation and investigate its effects on
the proliferative response in isolation. Only considering an extension to the
inflammation model presupposes that the interaction between the inflamma-
tory and proliferative responses in the wound is the most crucial in wound
repair. This may not be true, as angiogenesis is known to be intertwined
with proliferation.
Angiogenesis and proliferation occur at about the same time as fibroblasts
lay down the collagen through which the endothelial cells migrate as they
extend and develop the vasculature system. Indeed, supply of blood is cru-
cial to repair as oxygen levels are thought to be critical in wound closure.
Furthermore, oxygen affects the rate of recruitment of fibroblasts through
the wound space, the rate at which fibroblasts differentiate into myofibrob-
lasts and the apoptotic rate of myofibroblasts. We have shown that the role
of myofibroblasts in wound repair is crucial to wound contraction. Thus,
factors like oxygen concentration that affect these cells are certainly worth
consideration. Therefore, the inclusion of angiogenesis in future models
would be valuable to elucidate the mechanisms that lead to poor wound
repair.
Finally, the model developed represents a time-only description. However,
there are numerous aspects of wound repair that cannot be assessed through
this representation. Wound depth is known to influence the likelihood that
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a wound will develop with scar hypertrophy (Enoch and Leaper, 2007), and
both wound geometry and the anisotropic distribution of forces across the
wound influence wound closure and the cosmetic appearance of the result-
ing scar (Watts, 1960; McGrath and Simon, 1983). Indeed, other possible
indicators of scar quality such as collagen fibre alignment can only be consid-
ered within a spatially-dependent framework (Ferguson and O’Kane, 2004).
Hence, this model could be extended to include spatial dependence.
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Appendix A. Variable and Parameter Names
The following are the variables with their names as used in the model:
• n: Fibroblast density inside the wound
• m: Myofibroblast density inside the wound
• s: Collagen density inside the wound
• e: Effective strain inside the wound
• S: Collagen density outside the wound
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• E: Effective strain outside the wound
• L: Distance of wound boundary from wound center
Table A.1 lits the parameters prior to non-dimensionalization together with
their names and units.
Parameter Name Units
R Ingress of fibroblasts cm/day
g Fibroblast proliferation 1/day
r Fibroblast activation to myofibroblasts 1/N.(µg)2.day
a Myofibroblast apoptosis 1/day
b TGFβ decay 1/day
k1 Collagen production µg/cell.day
k2 Collagen degradation 1/cell.day
η Relative collagen production by myofibroblasts U
δ Relative collagen degradation by myofibroblasts U
kζ Contractile strain produced by fibroblasts 1/cells.µg.day
kρ Matrix turnover by fibroblasts µg/cells.day
piζ Myofibroblast to fibroblast contractile strain generation U
piρ Myofibroblast to fibroblast remodelling U
Y Elastic modulus N
τ Fibroblast cell traction N/cell
ζ Myofibroblast to fibroblast cell traction U
Table A.1: Table of parameters names and units. U refers to a parameter
with unit dimension.
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Appendix B. Parameter Estimates and Non-Dimensionalisation
Accurate parameter estimation is always an essential component of the mod-
elling process. In view of this, it is important to state any simplifying as-
sumptions before discussing parameter values. In our case:
• The proportionality constants for myofibroblast to fibroblast collagen
production and degradation are assumed to be equal, and we set η = δ.
• The proportionality constant for myofibroblast to fibroblast matrix
turnover is assumed to be the same as that of myofibroblast collagen
production, since these processes are essentially the same. Hence we
set piρ = η.
Before considering the remaining parameters, we estimate values for the
scalings used to non-dimensionalise the variables (see below).
α: A typical length scale for acute dermal wounds is 1cm.
g: It was chosen to scale time relative to fibroblast proliferation. Alberts
et al. (1989), Morgan and Pledger (1992) and Ghosh et al. (2007) state that
the average doubling time for for fibroblasts is approximately 18−20 hours.
This gives a range for the proliferation rate of 0.832 < g < 0.924, which is
consistent with curve fitting estimates for cell growth from Khorramizadeh
et al. (1999). We choose the lower limit, and so g = 0.832/day.
Nˆ : The carrying capacity of fibroblasts is known to be approximately 106/mL
(Vande Berg et al., 1989). Hence, we take Nˆ = 106cells/mL.
k1/k2: It is known that 30% of newly synthesized collagen is degraded (Au-
mailley et al., 1982). Hence, k2 = 0.3k1, such that k1/k2 = 3.33. The value
for k1 was chosen following order of magnitude approximations using nu-
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merical simulations, and was found to be approximately 0.1− 1µg/cell.day.
β0: Yang et al. (1999) found the initial concentration of TGFβ in the wound
to be 0.275ng/cm3. Hence, we take β0 = 0.275ng/cm
3.
We can now apply the following non-dimensionalisation:
L¯ =
L
α
, t¯ = gt, n¯ =
n
Nˆ
, m¯ =
m
Nˆ
, s¯ =
k2s
k1
, S¯ =
k2S
k1
,
e¯ = e, E¯ = E, βˆ =
β
β0
The values for the remaining dimensional parameters are as follows.
R: Experiments by Sillman et al. (2003) on collagen I found that fibroblasts
derived from normal human dermal wounds migrate at an average velocity
of 0.23− 0.36µm/min. This gives a range of 0.033 < R < 0.052cm/day. We
choose the lower limit of R = 0.033cm/day.
r: Desmouliere et al. (1993) found that culturing fibroblasts in the presence
of TGFβ increased the percentage of cells expressing α-SMA from 7.5% to
45.3%, representing an activation of 37.8% of fibroblasts. This is consis-
tent with other estimates (Masur et al., 1996; Moulin et al., 1996). The
Desmouliere experiment took place over a one week period, yielding an ap-
proximation of r ≈ 0.054/day.
Y : Estimates of Y range from 10 − 300N/cm2 (Silver et al., 2001; Genzer
and Groenewold, 2006). We consider an area of approximately 1cm2, which
gives a range of Y of 10 < Y < 300N. We use the estimate by Ahlfors and
Billiar (2007) of 71.3N/cm2, such that Y = 71.3N.
a: Moulin et al. (2004) estimate that 8 − 20% of myofibroblasts undergo
apoptosis. Hence, we choose a = 0.2/day.
b: The TGFβ decay rate was estimated from the exponential phase of the
data from Yang et al. (1999), giving a rate of b ≈ 0.354/day.
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η, δ: On a percentage basis, myofibroblasts produce roughly twice the col-
lagen that is synthesized by fibroblasts (Olsen et al., 1995; Moulin et al.,
1998; Kim and Friedman, 2009). Hence, we choose η = δ = 2.
kζ , kρ: During the non-dimensionalisation, it was seen that kζ and kρ are
both proportional to fibroblast synthesis. Further, since strain must be
small, this implies kζ  kρ. Based on this, we choose kζ = kρ/100.
piζ : This value is unknown. However, since myofibroblasts are much stronger
than fibroblasts, we suggest that piζ is approximately O(10).
τ : Values for τ differ by several orders of magnitude. By comparing some
reported experimental values and values used in other models of dermal
repair, it seems realistic to take τ = 2µN/cell. This is consistent with Fray
et al. (1998) and Wrobel et al. (2002).
ζ: Myofibroblasts are known to perform the majority of wound contraction,
and so a value of ζ = 5 was chosen (Olsen et al., 1995; Javierre et al., 2009).
Finally, the following non-dimensionalisation is used.
R˜ =
R
αg
, r˜ =
rK1n
gK2n
, Y˜ = Y, a˜ =
a
g
, b˜ =
b
g
κ =
K2nNˆ
g
, η˜ = η = δ = piρ, k˜ρ =
kρκ
k1
, k˜ζ =
kζk1κ
k22
, p˜i = piζ
τ˜ = τNˆ , ζ˜ = ζ.
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